Regenesis - About the company
Regenesis is a series C company based in Scottsdale (United States), founded in 1996. It operates as a Provider of at-home non-drug pain relief solutions for patients. Regenesis has raised $13.3M in funding from Fulcrum Equity Partners and TGap Ventures. The company has 126 active competitors, including 28 funded and 5 that have exited. Its top competitors include companies like Organogenesis, Acera Surgical and GeniPhys.
Company Details
Provider of at-home non-drug pain relief solutions for patients. It offers electromagnetic shortwave diathermy therapy devices to help in pain management which includes Reprieve 60, Reprieve Duo, and Reprive.
- Website
- www.regenesismed.com/
- Email ID
- *****@regenesismed.com, *****@regenesismed.com
- Phone Number
- +1 **********
- Registered Address
- Scottsdale, Arizona
Key Metrics
Founded Year
1996
Location
Scottsdale, United States
Stage
Series C
Total Funding
$13.3M in 4 rounds
Latest Funding Round
Investors
Ranked
13th among 126 active competitors
Employee Count
119 as on Sep 30, 2026
Similar Companies
Legal entities associated with Regenesis
Regenesis is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Reports |
|---|---|---|---|---|
REGENESIS BIOMEDICAL INC CIN: 32041517544 , United States, Active | $5M - $25M (As on Jun 10, 2011) | - | - | |
Regenesis Biomedical, Inc. CIN: 860947973 , United States, Active | Dec 31, 1995 | - | 62 (As on Dec 31, 2024) | - |
Sign up to download Regenesis' company profile
Regenesis's funding and investors
Regenesis has raised a total funding of $13.3M over 4 rounds. Its first funding round was on Apr 22, 2002. Its latest funding round was a Series C round on Jun 10, 2011 for $*****. 3 investors participated in its latest round. Regenesis has 5 institutional investors.
Here is the list of recent funding rounds of Regenesis:
Filter this list
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jun 10, 2011 | 1631488 | Series C | 4548542 | 9787342 | 2518920 | 1776623 |
Jun 01, 2007 | 6048698 | Series B | 4466393 | 9531470 | 7662383 | |
Jun 01, 2005 | 1275404 | Series B | 7971343 | 6931680 | 6544245 |
View details of Regenesis's funding rounds and investors
Regenesis' founders and board of directors
Founder? Claim ProfileRegenesis' employee count trend
Regenesis has 119 employees as of Sep 26. Here is Regenesis's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Regenesis's Competitors and alternates
Top competitors of Regenesis include Organogenesis, Acera Surgical and GeniPhys. Here is the list of Top 10 competitors of Regenesis, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Organogenesis 1985, Canton (United States), Public | Regenerative tissue innovations for advanced wound care and surgical solutions | $30M | 58/100 | |
2nd | Acera Surgical 2013, St. Louis (United States), Acquired | Provider of synthetic electrospun scaffolds for regenerative medical applications | $6.32M | 57/100 | |
3rd | GeniPhys 2014, Zionsville (United States), Series A | Developer of collagen polymers for tissue regeneration | $13.5M | 53/100 | |
4th | BioTissue 2001, Miami (United States), Series C | Developer of regenerative biologic therapies for eye care | $110M | 52/100 | |
5th | BioLab Holdings 2018, Mesa (United States), Unfunded | Manufacturer of synthetic antimicrobial matrices and single, dual, triple layer membranes | - | - | 49/100 |
6th | ![]() Conexeu Sciences 2023, Vancouver (Canada), Public | Developer of products for skin restoration and wound care | $6.96M | - | 47/100 |
7th | RenovoDerm 2016, Columbus (United States), Seed | Developer of nanofiber-based wound care devices | $775K | 46/100 | |
8th | Polaroid Therapeutics 2022, Schlieren (Switzerland), Unfunded | Developer of antimicrobial solutions for wound healing | - | - | 44/100 |
9th | Developer of patch system for wound healing | $52.4M | 44/100 | ||
10th | CLYRA Medical Technologies 2012, Westminster (United States), Seed | Developer of a regenerative technology for wound care | $50K | - | 44/100 |
13th | Regenesis 1996, Scottsdale (United States), Series C | Provider of at-home non-drug pain relief solutions for patients | $13.3M | 41/100 |
Looking for more details on Regenesis's competitors? Click here to see the top ones
Regenesis's Investments and acquisitions
Regenesis has made no investments or acquisitions yet.
Reports related to Regenesis
Here is the latest report on Regenesis's sector:
News related to Regenesis
•
Regenesis Biomedical Names Tom Eisiminger, Jr., Chief Executive OfficerPR Newswire•Jan 12, 2021•Regenesis
•
Regenesis Biomedical, Inc. Named Arizona Bioscience Company of the YearBusiness Wire•Sep 16, 2019•Regenesis, Regenesis Provant
•
Regenesis Biomedical Announces Series A FinancingPR Newswire•Apr 22, 2002•Regenesis, Solstice Capital, Village Ventures, Valley Ventures
Are you a Founder ?
FAQs about Regenesis
Explore our recently published companies
- Webspring - United Kingdom based, 2007 founded, Unfunded company
- Alka Lueders - Altenburg based, Unfunded company
- Paradigm Digital Group - Indianapolis based, 2002 founded, Unfunded company
- Finanzdienst 24 - Germany based, Unfunded company
- Delta Umwelttechnik - Germany based, 2002 founded, Unfunded company
- The Artisan's Place - Memphis based, Unfunded company
